Greediest players in US healthcare “honoured” in awards
BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l188 (Published 11 January 2019) Cite this as: BMJ 2019;364:l188- Mary Chris Jaklevic
- Chicago, USA
A drug company topped a list of the worst actors in US healthcare for the second year in a row, but other industry sectors—such as hospitals, physicians, and insurers—gained ground in the second annual Shkreli Awards.1
“This year we quite intentionally cast a wider net than just the well known and insane greed of the pharmaceutical sector,” said Vikas Saini, president of the Lown Institute, an advocacy group that bestows the awards, in an email. “We wanted to make the point that profiteering has become rampant and is not confined to any one particular sector of the healthcare enterprise.”
Three of the 10 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.